Multiple myeloma (A cancer arising from plasma cells)

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours

CAR-T therapy and impact to cancer patient outcomes and experience of treatment

Shared decision making (Patient-oncologist)

Engaging with policy makers

Challenges in evidence interpretation overcoming biases

Gordon McVie Lecture “Nag foundation": Delivering on outcomes that matter for cancer patients

Patient benefit vs industry benefit finding a balance

Balancing innovation and Common Sense In Oncology (CSO)

Common Sense in Oncology – Why

Integration of evidence-informed decision making into policymaking

Biostatistics for clinician researchers 1: Types of data